Skip to main content
logo
Jyong Biotech Ltd. (MENS)
NASDAQ: MENS · Real-Time Price · USD
2.270
+0.020 (0.89%)
Sep 3, 2026, 4:00 PM EDT - Market closed

Jyong Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-4.67-3.02-4.4-6.63-4.2
Depreciation & Amortization
0.10.120.130.120.12
Loss (Gain) From Sale of Investments
-0----
Other Operating Activities
-19.20.760.550.60.85
Change in Accounts Payable
-00-0-0.030.02
Change in Other Net Operating Assets
20.74-1.491.122.971.22
Operating Cash Flow
-3.04-3.62-2.6-2.97-1.98
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
----0.25-0.14
Investment in Securities
0-0.11.64-1.17
Other Investing Activities
-13.51----
Investing Cash Flow
-13.51-0.11.39-1.31

Financing Activities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
23.19.249.811.345.62
Long-Term Debt Issued
1.382.432.030.940.02
Total Debt Issued
24.4711.6711.8312.285.64
Short-Term Debt Repaid
-22.94-9.39-9.11-8.38-5.57
Long-Term Debt Repaid
-1.56-0.07-0.24-0.29-1.45
Total Debt Repaid
-24.5-9.47-9.36-8.67-7.02
Net Debt Issued (Repaid)
-0.022.22.473.61-1.38
Issuance of Common Stock
17.77----
Other Financing Activities
-0.11-0.21-0.45-0.28-
Financing Cash Flow
17.631.992.033.33-1.38

Net Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.01-0.01-0.05-0.030.07
Net Cash Flow
1.08-1.64-0.531.72-4.61

Free Cash Flow

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-3.04-3.62-2.6-3.22-2.12
Free Cash Flow Growth
-----
Free Cash Flow Per Share
-0.04-0.05-0.04-0.04-0.03
Levered Free Cash Flow
4.39-1.73-1.040.22-0.01
Unlevered Free Cash Flow
5.97-1.08-0.570.70.51

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
0.340.220.10.160.11
Change in Working Capital
20.74-1.491.122.941.24
SEC Filings: 10-K · 10-Q